As on Wednesday, GeneDx Holdings Corp (NASDAQ: WGS) got off with the flyer as it spiked 1.61% to $130.06, before settling in for the price of $128.0 at the close. Taking a more long-term approach, WGS posted a 52-week range of $55.17-$170.87.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 96.65%. Meanwhile, its Annual Earning per share during the time was 96.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 432.09%. This publicly-traded company’s shares outstanding now amounts to $28.89 million, simultaneously with a float of $25.35 million. The organization now has a market capitalization sitting at $3.76 billion. At the time of writing, stock’s 50-day Moving Average stood at $141.94, while the 200-day Moving Average is $107.94.
GeneDx Holdings Corp (WGS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Diagnostics & Research industry. GeneDx Holdings Corp’s current insider ownership accounts for 12.28%, in contrast to 103.77% institutional ownership. According to the most recent insider trade that took place on Dec 16 ’25, this organization’s CHIEF FINANCIAL OFFICER sold 3,855 shares at the rate of 143.87, making the entire transaction reach 554,616 in total value, affecting insider ownership by 8,731. Preceding that transaction, on Dec 16 ’25, Company’s CHIEF EXECUTIVE OFFICER sold 10,857 for 143.89, making the whole transaction’s value amount to 1,562,185. This particular insider is now the holder of 14,237 in total.
GeneDx Holdings Corp (WGS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year. GeneDx Holdings Corp’s EPS increase for this current 12-month fiscal period is 432.09% and is forecasted to reach 0.43 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 87.47% through the next 5 years, which can be compared against the 96.65% growth it accomplished over the previous five years trading on the market.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Let’s observe the current performance indicators for GeneDx Holdings Corp (WGS). It’s Quick Ratio in the last reported quarter now stands at 2.59. Alongside those numbers, its PE Ratio stands at $2156.88, and its Beta score is 2.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.35. Similarly, its price to free cash flow for trailing twelve months is now 243.01.
In the same vein, WGS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.06, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be 0.43 at the market close of one year from today.
Technical Analysis of GeneDx Holdings Corp (WGS)
Through scrutinizing the latest numbers posted by the [GeneDx Holdings Corp, WGS], it can be observed that its last 5-days Average volume of 0.33 million was lower the volume of 0.86 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 13.52% While, its Average True Range was 29.30.
Raw Stochastic average of GeneDx Holdings Corp (WGS) in the period of the previous 100 days is set at 38.58%, which indicates a major rise in contrast to 14.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 6.56 that was lower than 7.27 volatility it exhibited in the past 100-days period.
